The US Food and Drug Administration (FDA) is warning about cases of necrotizing fasciitis of the perineum in patients taking sodium-glucose cotransporter-2 (SGLT2) inhibitors.
Those drugs include the following:
Canagliflozin (Invokana, Invokamet, Invokamet XR; Janssen)
Dapagliflozin (Farxiga, Xigduo XR, Qtern, AstraZeneca)
Empagliflozin (Jardiance, Glyxambi, Synjardy, Synjardy XR; Boehringer Ingelheim/Eli Lilly)
Ertugliflozin (Steglatro, Segluromet, Stelujan; Merck)
